Edith Mitchell, M.D., to Speak at 2nd Annual Kentmere Genetic Testing and Utilization Management Conference in Philadelphia

WILMINGTON, Del., June 8, 2016 /PRNewswire/ -- Edith Mitchell, M.D., Program Leader of Gastrointestinal Oncology at Sidney Kimmel Medical College at Thomas Jefferson University, has been announced to speak at Kentmere Healthcare Consulting Corporation's 2^nd Annual Genetic Testing and Utilization Management Conference, June 23-24, 2016 in Philadelphia.

Logo - http://photos.prnewswire.com/prnh/20160607/376602LOGO

Edith Peterson Mitchell, M.D. is Board Certified in Internal Medicine and Medical Oncology and is Clinical Professor, Department of Medicine and Medical Oncology, Program Leader, Gastrointestinal Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and Associate Director for Diversity Programs and Director of the Center to Eliminate Cancer Disparities for the Sidney Kimmel Cancer Center at Jefferson. Dr. Mitchell also is a retired brigadier general in the U.S. Air Force, and was the first female physician to attain this rank.

As a practicing medical oncologist, Mitchell's research interests have included many cancer types such as breast, colorectal, pancreatic and other gastrointestinal malignancies. Her work has focused on developing new therapies as well as working toward better and more effective strategies and regimens using existing techniques. She has more than 100 publications in journals, book chapters and abstracts. She has received numerous grants in support of her work and served on several National Cancer Institute review panels.

Nationally, Dr. Mitchell is President of the National Medical Organization and is very active in community affairs that promote health and cancer prevention.

At the conference, Dr. Mitchell will speak on the topic, "Colorectal Cancer: Genetic Testing for Screening, Susceptibility, Prognosis, and Targeted Therapies – What is a Clinician to Do!" The discovery of mutations in genes that render individuals susceptible to colorectal cancer has placed a new emphasis on screening, and non-invasive tests have been developed to compete with colonoscopy.  Furthermore, gene profiling can both identify patients with colorectal cancer that need chemotherapy as well as help determine the type of chemotherapy.  Dr. Mitchell will describe how the oncology community is attempting to deal with this constantly evolving challenges.

Additional conference topics include:

• The Power of NGS: Non-Invasive Prenatal Testing and Liquid Biopsies
• Pharmacogenomics and the Basis of Targeted, Personalized Therapies: The Right Drug at the Right Time to the Right Person
• Navigating the Minefield of Genetic Testing UM; Operational, Financial and Medical

Additional conference speakers include:

• Russel Kaufman, MD, FACP, FCCP, Chief Medical Officer, Kentmere Healthcare Consulting Corporation; Hematologist/Oncologist and Cancer Geneticist; former Dean and Vice-Chancellor, Duke University Medical School; former CEO, The Wistar Institute
• Mike Barlow, Vice President, Palmetto GBA, Centers for Medicare & Medicaid Services Medicare Administrative Contractors
• Elaine Jeter, MD, MolDx Medical Director, Palmetto GBA, Centers for Medicare & Medicaid Services Medicare Administrative Contractors

The Kentmere Genetic Testing and Utilization Management Conference is designed for Health Plans and will present the latest ideas on where they should focus their efforts for genetic testing in the future, as well as the latest news on CMS genetic testing reimbursement and American Association for Cancer Research cancer genetic testing. It is exclusively for Health Plan and ACO Medical Directors, Network Management Executives, Medical Policy and Reimbursement/Contracting personnel, as well as anyone involved in utilization management of genetic and laboratory tests.

Registration* and further information can be found at http://kentmere-healthcare-consulting.ticketleap.com/2016genetic

*Kentmere has the right to deny admission and refund ticket purchases made by or for any organization and/or person that is not a Health Plan or ACO or an employee of a Health Plan or ACO.

About Kentmere Healthcare Consulting Corporation

Since 2000, Kentmere Healthcare Consulting Corporation provides its proprietary outpatient Kentmere Laboratory Benefit Management Program™ for the managed care industry, which manages Health Plan utilization, cost, and mix of outpatient clinical, pathology, and genomic laboratory testing. Kentmere exclusively serves national and regional health plans, is not a laboratory, and does not work for or with laboratory providers.

Contact:
Danielle Ellis, Kentmere Healthcare Consulting Corporation
302-478-7600 / Email

SOURCE Kentmere Healthcare Consulting